Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 631

1.

Drop in CD4+ counts below 200 cells/µL after reaching (or starting from) values higher than 350 cells/µL in HIV-infected patients with virological suppression.

Gianotti N, Marchetti G, Antinori A, Saracino A, Gori A, Rizzardini G, Lichtner M, Bandera A, Mussini C, Girardi E, Monforte AD, Cozzi-Lepri A; ICONA Foundation Study Group.

J Acquir Immune Defic Syndr. 2017 Aug 12. doi: 10.1097/QAI.0000000000001522. [Epub ahead of print]

PMID:
28816721
2.

Multiple epitope presentation and surface density control enabled by chemoselective immobilization lead to enhanced performance in IgE-binding fingerprinting on peptide microarrays.

Gori A, Cretich M, Vanna R, Sola L, Gagni P, Bruni G, Liprino M, Gramatica F, Burastero S, Chiari M.

Anal Chim Acta. 2017 Aug 29;983:189-197. doi: 10.1016/j.aca.2017.06.027. Epub 2017 Jun 20.

PMID:
28811026
3.

3-Year efficacy and durability of simplification to single tablet regimens: a comparison between co-formulated efavirenz/emtricitabine/tenofovir and rilpivirine/emtricitabine/tenofovir.

Gagliardini R, Bandera A, Zaccarelli M, Sterrantino G, Latini A, D'Avino A, Lapadula G, Antinori A, Cauda R, De Luca A, Gori A, Di Giambenedetto S, Fabbiani M.

Antivir Ther. 2017 Aug 11. doi: 10.3851/IMP3188. [Epub ahead of print]

PMID:
28799920
4.

Nosocomial Infections During Extracorporeal Membrane Oxygenation: Incidence, Etiology, and Impacton Patients' Outcome.

Grasselli G, Scaravilli V, Di Bella S, Biffi S, Bombino M, Patroniti N, Bisi L, Peri AM, Pesenti A, Gori A, Alagna L.

Crit Care Med. 2017 Aug 2. doi: 10.1097/CCM.0000000000002652. [Epub ahead of print]

PMID:
28777198
5.

Morning dosing for dolutegravir-related insomnia and sleep disorders.

Capetti AF, Di Giambenedetto S, Latini A, Sterrantino G, De Benedetto I, Cossu MV, Gori A.

HIV Med. 2017 Aug 1. doi: 10.1111/hiv.12540. [Epub ahead of print] No abstract available.

PMID:
28762661
6.

Disulfide Bond Mimetics: Strategies and Challenges.

Gori A, Gagni P, Rinaldi S.

Chemistry. 2017 Jul 27. doi: 10.1002/chem.201703199. [Epub ahead of print]

PMID:
28749012
7.

PrEP in Italy: The time may be ripe but who's paying the bill? A nationwide survey on physicians' attitudes towards using antiretrovirals to prevent HIV infection.

Di Biagio A, Riccardi N, Signori A, Maserati R, Nozza S, Gori A, Bonora S, Borderi M, Ripamonti D, Rossi MC, Orofino G, Quirino T, Nunnari G, Celesia BM, Martini S, Sagnelli C, Mazzola G, Colletti P, Bartolozzi D, Bini T, Ladisa N, Castelnuovo F, Saracino A, Lo Caputo S.

PLoS One. 2017 Jul 20;12(7):e0181433. doi: 10.1371/journal.pone.0181433. eCollection 2017.

8.

Designing Probes for Immunodiagnostics: Structural Insights into an Epitope Targeting Burkholderia Infections.

Capelli R, Matterazzo E, Amabili M, Peri C, Gori A, Gagni P, Chiari M, Lertmemongkolchai G, Cretich M, Bolognesi M, Colombo G, Gourlay LJ.

ACS Infect Dis. 2017 Jul 21. doi: 10.1021/acsinfecdis.7b00080. [Epub ahead of print]

PMID:
28707874
9.

Halogenation dictates the architecture of amyloid peptide nanostructures.

Pizzi A, Pigliacelli C, Gori A, Nonappa, Ikkala O, Demitri N, Terraneo G, Castelletto V, Hamley IW, Baldelli Bombelli F, Metrangolo P.

Nanoscale. 2017 Jul 20;9(28):9805-9810. doi: 10.1039/c7nr03263c.

PMID:
28696473
10.

Fine-mapping inflammatory bowel disease loci to single-variant resolution.

Huang H, Fang M, Jostins L, Umićević Mirkov M, Boucher G, Anderson CA, Andersen V, Cleynen I, Cortes A, Crins F, D'Amato M, Deffontaine V, Dmitrieva J, Docampo E, Elansary M, Farh KK, Franke A, Gori AS, Goyette P, Halfvarson J, Haritunians T, Knight J, Lawrance IC, Lees CW, Louis E, Mariman R, Meuwissen T, Mni M, Momozawa Y, Parkes M, Spain SL, Théâtre E, Trynka G, Satsangi J, van Sommeren S, Vermeire S, Xavier RJ; International Inflammatory Bowel Disease Genetics Consortium, Weersma RK, Duerr RH, Mathew CG, Rioux JD, McGovern DPB, Cho JH, Georges M, Daly MJ, Barrett JC.

Nature. 2017 Jul 13;547(7662):173-178. doi: 10.1038/nature22969. Epub 2017 Jun 28.

PMID:
28658209
11.

Peripheral monocytes/macrophages phenotypes associated to the evolution of cognitive performance in HIV-infected patients.

Fabbiani M, Muscatello A, Perseghin P, Bani M, Incontri A, Squillace N, Lapadula G, Gori A, Bandera A.

J Acquir Immune Defic Syndr. 2017 Jun 19. doi: 10.1097/QAI.0000000000001480. [Epub ahead of print]

PMID:
28639993
12.

Safety and tolerability of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil fumarate in a real life setting: Data from surveillance cohort long-term toxicity antiretrovirals/antivirals (SCOLTA) project.

Squillace N, Ricci E, Quirino T, Gori A, Bandera A, Carenzi L, De Socio GV, Orofino G, Martinelli C, Madeddu G, Rusconi S, Maggi P, Celesia BM, Cordier L, Vichi F, Calza L, Falasca K, Di Biagio A, Pellicanò GF, Bonfanti P; CISAI Study Group.

PLoS One. 2017 Jun 20;12(6):e0179254. doi: 10.1371/journal.pone.0179254. eCollection 2017.

13.

Development and performance of a diagnostic/prognostic scoring system for breakthrough pain.

Samolsky Dekel BG, Palma M, Sorella MC, Gori A, Vasarri A, Melotti RM.

J Pain Res. 2017 May 31;10:1327-1335. doi: 10.2147/JPR.S126132. eCollection 2017.

14.

Symptomatic efficacy of buckwheat products in Non-Celiac Gluten Sensitivity (NCGS).

Dinu M, Macchia D, Pagliai G, Gori AM, Cesari F, Marcucci R, Sofi F, Casini A.

Asia Pac J Clin Nutr. 2017;26(4):630-636. doi: 10.6133/apjcn.072016.07.

15.

Infections during extracorporeal membrane oxygenation: epidemiology, risk factors, pathogenesis and prevention.

Biffi S, Di Bella S, Scaravilli V, Peri AM, Grasselli G, Alagna L, Pesenti A, Gori A.

Int J Antimicrob Agents. 2017 Jul;50(1):9-16. doi: 10.1016/j.ijantimicag.2017.02.025. Epub 2017 May 18. Review.

PMID:
28528989
16.

Access and response to direct antiviral agents (DAA) in HIV-HCV co-infected patients in Italy: Data from the Icona cohort.

d'Arminio Monforte A, Cozzi-Lepri A, Ceccherini-Silberstein F, De Luca A, Lo Caputo S, Castagna A, Mussini C, Cingolani A, Tavelli A, Shanyinde M, Gori A, Girardi E, Andreoni M, Antinori A, Puoti M; Icona Foundation and HepaIcona Study Group.

PLoS One. 2017 May 17;12(5):e0177402. doi: 10.1371/journal.pone.0177402. eCollection 2017.

17.

Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update 2016.

Antinori A, Di Biagio A, Marcotullio S, Andreoni M, Chirianni A, d'Arminio Monforte A, Galli M, Mazzotta F, Mussini C, Puoti M, Lazzarin A; Italian HIV Guidelines Working Group.

New Microbiol. 2017 Apr;40(2):86-98.

18.

Feasibility and relevance of right parasternal view for assessing severity and rate of progression of aortic valve stenosis in primary care.

Benfari G, Gori AM, Rossi A, Papesso B, Vassanelli C, Zito GB, Nistri S.

Int J Cardiol. 2017 Aug 1;240:446-451. doi: 10.1016/j.ijcard.2017.04.091. Epub 2017 May 3.

PMID:
28499670
19.

Efficacy and tolerability of switching to a dual therapy with darunavir/ritonavir plus raltegravir in HIV-infected patients with HIV-1 RNA ≤50 cp/mL.

Madeddu G, Rusconi S, Cozzi-Lepri A, Di Giambenedetto S, Bonora S, Carbone A, De Luca A, Gianotti N, Di Biagio A, Antinori A; Icona Foundation Study Group.

Infection. 2017 Aug;45(4):521-528. doi: 10.1007/s15010-017-1018-z. Epub 2017 May 5.

PMID:
28477212
20.

Serum albumin level and hospital mortality in acute non-ischemic heart failure.

Ancion A, Allepaerts S, Oury C, Gori AS, Piérard LA, Lancellotti P.

ESC Heart Fail. 2017 May;4(2):138-145. doi: 10.1002/ehf2.12128. Epub 2017 Jan 13.

Supplemental Content

Loading ...
Support Center